Together with T classification (p < 0.001) and residual tumor (p = 0.006), MAST2 expression (HR = 2.110, 95%CI: 1.467–3.035, p = 0.000) was independent risk factor for OS in liver cancer patients (Table 3) after adjusting the other variables correlated with OS (stage, T classification, and residual tumor). Here, MAST2 is linked to neoplasm.